Date published: 2026-5-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Brachyury Inhibitors

Brachyury, also known as the T-box transcription factor T (T-BXT), is a transcription factor that plays a pivotal role in the embryonic development of many organisms. Its function is primarily associated with the formation of the notochord, a structure essential for the development of the vertebral column in vertebrates. Brachyury belongs to the T-box family of transcription factors, characterized by a DNA-binding domain known as the T-box. This domain enables Brachyury to bind specific DNA sequences, thereby regulating the expression of target genes involved in developmental processes. In addition to its well-documented role in embryogenesis, Brachyury has been found to be expressed in various tumors, suggesting its involvement in processes beyond development. Brachyury inhibitors are a class of chemical compounds designed to target and modulate the activity of Brachyury. Given the protein's role in gene regulation, these inhibitors often work by preventing Brachyury from binding to DNA, thereby disrupting its transcriptional activity. The development of these inhibitors is rooted in an intricate understanding of the molecular structure and function of Brachyury, especially the T-box domain. Sophisticated techniques in molecular biology, structural biology, and computational modeling are employed to design molecules that can specifically target this transcription factor. By inhibiting Brachyury, researchers can gain insights into its mechanistic roles in various cellular processes, including those that might be relevant in
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$36.00
$117.00
$525.00
26
(1)

XAV-939 is a Wnt/β-catenin pathway inhibitor. Since the Wnt/β-catenin pathway plays a role in brachyury expression, its inhibition can down-regulate brachyury.

KY02111

1118807-13-8sc-397043
sc-397043A
5 mg
25 mg
$79.00
$336.00
(0)

KY02111 promotes degradation of β-catenin, leading to inhibition of the Wnt/β-catenin pathway and potential down-regulation of brachyury.

JW 55

664993-53-7sc-364517
sc-364517A
10 mg
50 mg
$172.00
$726.00
(0)

JW 55 is another inhibitor of the Wnt/β-catenin pathway, which can lead to reduced brachyury expression.

Cardamonin

19309-14-9sc-293984
sc-293984A
10 mg
50 mg
$224.00
$940.00
(1)

Cardamonin is a natural compound that has been shown to inhibit the Wnt/β-catenin pathway, potentially reducing brachyury levels.

PRI-724

1422253-38-0sc-507535
25 mg
$260.00
(0)

PRI-724 is a specific inhibitor of the interaction between β-catenin and its coactivator CBP. This can disrupt the Wnt/β-catenin pathway and down-regulate brachyury.

β-Catenin/Tcf Inhibitor, FH535

108409-83-2sc-221398
sc-221398A
10 mg
50 mg
$182.00
$374.00
7
(1)

FH535 is an inhibitor of both the Wnt/β-catenin and PPAR pathways. It might down-regulate brachyury through its effect on the Wnt pathway.

LGK 974

1243244-14-5sc-489380
sc-489380A
5 mg
50 mg
$359.00
$1295.00
2
(0)

LGK974 is an inhibitor of Porcupine, an enzyme necessary for Wnt ligand secretion. By inhibiting Wnt signaling, it can potentially reduce brachyury expression.

Wnt-C59

1243243-89-1sc-475634
sc-475634A
sc-475634B
5 mg
10 mg
50 mg
$214.00
$326.00
$1275.00
1
(0)

Wnt-C59 is a Porcupine inhibitor that can block Wnt signaling and potentially down-regulate brachyury.

IQ-1

331001-62-8sc-202665
10 mg
$180.00
2
(1)

IQ-1 is a specific inhibitor of the interaction between β-catenin and its coactivator p300. By doing so, it might reduce brachyury expression.